Market Overview

UPDATE: Morgan Stanley Downgrades Priceline.com to Equal-Weight on Rising Costs

Share:
Related PCLN
Wall Street's M&A Chatter From March 23: Citrix, Dow-Dupont, TripAdvisor
10 Most Innovative States In America
Joel Greenblatt Raises Holdings of CVS Health, Priceline, HP (GuruFocus)

Morgan Stanley downgraded Priceline.com Incorporated (NASDAQ: PCLN) from Overweight to Equal-weight and lowered the price target from $750.00 to $730.00.

Morgan Stanley commented, "Over the next three years, we expect PCLN to grow bookings at a 19% CAGR and EBITDA margins to contract by 220bps. PCLN is entering a new landscape with a strong number two competitor in Europe (Expedia, Equal-weight). We expect greater online advertising deleverage due to a more competitive environment for paid search marketing, Google's travel initiatives and lower advertising ROI in newer markets. Furthermore, the rapid shift to mobile bookings is a threat to PCLN given its core expertise lies in desktop SEM."

Priceline.com closed at $695.09 on Wednesday.

Latest Ratings for PCLN

DateFirmActionFromTo
Jan 2017MKM PartnersInitiates Coverage OnBuy
Jan 2017MKM PartnersInitiates Coverage OnBuy
Jan 2017CitigroupInitiates Coverage OnBuy

View More Analyst Ratings for PCLN
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Downgrades Analyst Ratings

 

Related Articles (PCLN)

View Comments and Join the Discussion!